From a clinical perspective there are several pharmacological alternatives for osteoporosis such as bisphosphonates, selective estrogen receptor modulators (SERMs), Hormone replacement therapy (HRT), Teriparatide and Denosumab, among others. This evidence concerns the gene ESR1 and osteoporosis.